Company Data
Lyell Immunopharma Inc.
Ticker
LYEL
Current Price
$13.5 -1.6%
Market Cap
$315.0M
Price Target
Refer to Report
Volume
99.9K
52wk Range
$8.46 - $45
Overview
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).